LATEST NEWS
At MEDSCAN Merrylands, we are committed to providing the latest in medical technology for our patients and doctors. Our new Siemens Photon Counting CT offers enhanced imaging capabilities, while the GE MRI 3T HERO ensures precise diagnostics. Additionally, we are proud to introduce Euflexxa Injections for Osteo Arthritis pain and our Lung Cancer Screening Program, designed to detect potential issues early and improve patient outcomes. Your health is our priority, and we are here to support you every step of the way.
1
New Siemens Photon Counting CT
Introducing the Siemens Photon Counting CT, a revolutionary advancement in medical imaging technology. This cutting-edge system enhances diagnostic accuracy while minimising radiation exposure, providing healthcare professionals with clearer, more images. With its innovative design and advanced capabilities, the Siemens Photon Counting CT is set to redefine patient care.
2
New GE 3T hero MRI
Introducing the new GT Hero 3T MRI, a state-of-the imaging solution that promises exceptional precision and clarity. with advanced technology, it prioritises patient comfort while equipping radiologists with detailed images for accurate diagnoses. This innovative tool is set to elevate the standard of care for both patients and medical professionals alike.
3
Euflexxa Injections
Euflexxa is an injectable treatment designed to alleviate joint pain associated with osteoarthritis. By providing lubrication and cushioning in the joint, it helps improve mobility and reduce discomfort Administered by a healthcare professional, Euflexxa can be an effective option for those seeking relief from their symptoms. Speak with your doctor to determine if Euflexxa is suitable for needs.
4
Lung Cancer Screening
Lung cancer screening is a vital step in early detection and prevention. It involves using low-dose CT scans to identify potential signs of lung cancer in high-risk individuals. By catching the disease early, patients have a better chance of successful treatment and improved outcomes.